Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 20 Lymphoma 6 Urinary Bladder Neoplasms 3 Urothelial Carcinoma of the Bladder 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Choroid Plexus Neoplasms 1 Childhood Solid Tumor 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Astrocytoma 1

Interventions

Cyclophosphamide 9 Biopsy 5 Specimen Handling 4 Prednisone 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 fludarabine 3 Vincristine 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 alectinib 2 X-Rays 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × Vinblastine × 1 year × Clear all

NCT07013565 2026-05-20

ACCELERATE

New York Medical College

Phase 2 Recruiting

Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡